AI
Monday, December 10, 2007 10:04:55 PM
Very good! I thought the graphic would make it a little harder for Biowatch to find the answer but you didn't even give her a chance :).
Data on top 15 Biotech companies compiled by Compensia, Inc. as of August 16, 2007. The source of the graphics came from United Therapeutics November CIBC presentation available at http://ir.unither.com/events.cfm [the very small hint was for those wanting to cheat if you were familiar with companies I post about you could have found it. OK I confess the hint was more to try and throw people off].
Revenue / Employee
1. Gilead
2. Genentech
3. Celgene
4. Biogen
5. Amgen
6. MGI
7. Cephalon
8. United Therapeutics
9. OSI Pharma
10. Imclone
11. Millennium
12. Abraxis
13. PDL
14. Amylin
15. Genzyme
Market Capitalization / Employee
1. Celgene
2. Gilead
3. Genentech
4. United Therapeutics
5. Biogen
6. Amylin
7. MGI
8. OSI Pharma
9. Millennium
10. Imclone
11. Amgen
12. PDL
13. Abraxis
14. Genzyme
16. Cephalon
Market Capitalization / Employee
Revenue / Employee
Data on top 15 Biotech companies compiled by Compensia, Inc. as of August 16, 2007. The source of the graphics came from United Therapeutics November CIBC presentation available at http://ir.unither.com/events.cfm [the very small hint was for those wanting to cheat if you were familiar with companies I post about you could have found it. OK I confess the hint was more to try and throw people off].
Revenue / Employee
1. Gilead
2. Genentech
3. Celgene
4. Biogen
5. Amgen
6. MGI
7. Cephalon
8. United Therapeutics
9. OSI Pharma
10. Imclone
11. Millennium
12. Abraxis
13. PDL
14. Amylin
15. Genzyme
Market Capitalization / Employee
1. Celgene
2. Gilead
3. Genentech
4. United Therapeutics
5. Biogen
6. Amylin
7. MGI
8. OSI Pharma
9. Millennium
10. Imclone
11. Amgen
12. PDL
13. Abraxis
14. Genzyme
16. Cephalon
Market Capitalization / Employee
Revenue / Employee
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
